Product Information

LEVOTHYROXINE 137 MCG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.0635 per EA under NDC 31722029110. Its NADAC has been published 163 times since Oct 11, 2023.

FDA first approved this application on Jan 18, 2023. Its Orange Book therapeutic-equivalence code is AB4 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LEVOTHYROXINE 137 MCG TABLET

levothyroxine sodium
$0.0635per EA

Strength

.137 mg/1

NDC

31722029110

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

LEVOTHYROXINE SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA215259

FDA Approved

1/18/2023

TE Code

AB4

On Market Since

1/18/2023

Pharmacological Classes

Thyroxine
l-Thyroxine

Price Statistics

The NADAC for LEVOTHYROXINE 137 MCG TABLET has been published 163 times since Oct 11, 2023, and over the history we have for it it has declined 28.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0635 per EA
All-time high$0.1054 (Dec 13, 2023)
All-time low$0.0555 (Jul 17, 2024)
52-week high$0.0755
52-week low$0.0624
Median price$0.0742
Average price$0.0746
Largest weekly change+51.0% (Jun 19, 2024)
Weeks tracked163
Tracking sinceOct 11, 2023

Price History

1W

+0.3%

1M

-0.7%

3M

+1.1%

6M

-1.3%

1Y

-15.3%

3Y

-22.6%

5Y

N/A

All

-28.1%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LEVOTHYROXINE 137 MCG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LEVOTHYROXINE 137 MCG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.0635 per EA (NDC 31722029110), effective Nov 18, 2026.

How has the price of LEVOTHYROXINE 137 MCG TABLET changed over time?

Over the history we have for it, the NADAC for LEVOTHYROXINE 137 MCG TABLET has declined 28.1%. It has been tracked across 163 weekly CMS publications since Oct 11, 2023.

What are the highest and lowest recorded NADAC prices for LEVOTHYROXINE 137 MCG TABLET?

Since Oct 11, 2023, the NADAC for LEVOTHYROXINE 137 MCG TABLET has ranged from a low of $0.0555 (Jul 17, 2024) to a high of $0.1054 (Dec 13, 2023), with a median of $0.0742 per EA.

Are there cheaper alternatives to LEVOTHYROXINE 137 MCG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as LEVOTHYROXINE 137 MCG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures LEVOTHYROXINE 137 MCG TABLET?

LEVOTHYROXINE 137 MCG TABLET (NDC 31722029110) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.